Market Overview

Global Biologics Manufacturing Market 2018-2022| Introduction of New Biologic Drugs to Spur Growth| Technavio


The global biologics manufacturing market 2018-2022 is expected to post
a CAGR of more than 9% during the forecast period, according to the
latest market research report by Technavio.

This press release features multimedia. View the full release here:

Technavio has published a new market research report on the global biologics manufacturing market fr ...

Technavio has published a new market research report on the global biologics manufacturing market from 2018-2022. (Graphic: Business Wire)

A key factor driving the growth of the market is the introduction of new
biologic drugs for treating diseases. The demand for biologics for the
more effective treatment of diseases is growing as synthetic drugs have
several limitations. Therefore, the development of new biologics for the
treatment of existing disorders and rare conditions is expected to fuel
the growth of the biologics manufacturing industry during the forecast

This market research report on the global
biologics manufacturing market 2018-2022
also provides an
analysis of the most important trends expected to impact the market
outlook during the forecast period. Technavio classifies an emerging
trend as a major factor that has the potential to significantly impact
the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

In this report, Technavio highlights the rise in partnership between
biopharma companies and biotechnology startups as one of the key
emerging trends in the global biologics development process market:

Global biologics manufacturing market: Rise in
partnership between biopharma companies and biotechnology startups

The significant growth of the biologics industry and biotech companies
in the past few years has encouraged several major traditional biopharma
companies to collaborate with the biotechnology startups to develop
novel biologic drugs. Traditional biopharma companies are collaborating,
investing, licensing the technology, as well as acquiring startup
companies to leverage their expertise for faster drug development.

"Several medical companies are working on advanced drug development
for medical care that can possibly change the market landscape of the
biologics industry in the coming years. Plenty of biotech companies are
in the early to late stage of clinical testing and are expected to bring
low-cost drugs to the market during the forecast period, which can
considerably impact the business process of large pharma companies.
Hence, traditional biopharma companies are investing in building
partnerships with such startups during the early phase of drug
says a senior analyst at Technavio for research on
infectious and rare diseases.

Global biologics manufacturing market:
Segmentation analysis

This market research report segments the global biologics manufacturing
process market by product (biologics and biosimilars), by technology
(in-house and outsourced) and geographical regions (APAC, EMEA, and the

The Americas led the market in 2017 with a market share of more than
52%, followed by APAC and EMEA respectively. Although APAC held the
smallest share of the market, it is expected to witness the maximum
increase in its market share over the forecast period.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!